ArticleBMC musculoskeletal disorders2026
The prevention of heterotopic ossification around the knee: a scoping review.
Article in BMC musculoskeletal disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEvidence on prophylactic interventions to prevent heterotopic ossification (HO) around the knee is scarce. We conducted a scoping review to map reported indications, interventions, and outcome reporting.
methodsWe followed a prospectively developed protocol and searched four major databases (MEDLINE via PubMed, Embase, Cochrane Library, and Web of Science), complemented by searches of trial registries and grey literature using a high-sensitivity strategy. Data extraction was performed in duplicate and summarized descriptively by modality.
resultsThe search yielded 2,958 records. We included 78 unique publications, comprising 18 expert-opinion sources and 62 clinical publications reporting data on 3,321 patients, of whom 1,579 received the evaluated interventions, with two publications contributing to both syntheses. Modalities comprised continuous passive motion (CPM) in 8, pharmacological prophylaxis in 21, radiotherapy (RT) in 18, surgical techniques in 3, and combination therapy in 14 studies. Most identified studies were case reports or case series. Pharmacological data were largely driven by one large ASA cohort, whereas RT and combination-therapy studies were small and mainly addressed recurrence prophylaxis. One late fatal, potentially RT-induced sarcoma was reported. Because of substantial clinical and methodological heterogeneity, crude reported event proportions should not be compared directly across modalities. Outcome reporting was inconsistent, with limited use of standardized patient-reported outcomes and incomplete adverse-event reporting.
conclusionsKnee HO prophylaxis evidence is dominated by low-level, heterogeneous studies with substantial reporting gaps. Comparative knee-specific studies with standardized outcome definitions, functional outcomes, and systematic safety reporting are needed.
trial registrationThis review was prospectively registered on the Open Science Framework (OSF registration ID 5328k).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.